Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2011 by Echosense Ltd.
Information provided by (Responsible Party):
Echosense Ltd. Identifier:
First received: October 19, 2010
Last updated: June 24, 2014
Last verified: May 2011

October 19, 2010
June 24, 2014
August 2010
May 2015   (final data collection date for primary outcome measure)
Diagnose specific pattern of LDS signals as Power and Velocity in pulmonary diseases in comparison to controls. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01225367 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases
Detection and Characterization of Cardio-pulmonary Patho-physiological States and Diseases by Ultrasound Transthoracic Doppler

The study is a prospective open evaluating study of Ultrasound/Doppler application to the chest cavity intended to detect and characterize pathologies of the pulmonary and cardio-vascular system.

The system is a noninvasive non-imaging device designated to monitor flow and movement velocity and display the data continuously.

Not Provided
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

primary care clinic

  • Pulmonary Pathologies
  • Cardio-pulmonary Diseases
Device: ultrasound doppler monitoring
Regular noninvasive chest echo monitoring
pulmonary doppler
Intervention: Device: ultrasound doppler monitoring
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
December 2015
May 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18y or older
  • patients who are clinically suspected of having a significant pulmonary or cardio-pulmonary disease
  • Patients with CHF
  • Patients with pulmonary hypertension
  • Patients with COPD
  • Patients with Asthma
  • Signed informed consent
  • Normal subjects

Exclusion Criteria:

  • Patients with unstable conditions: unstable angina, uncontrolled CHF, etc
  • Inability to assume a sitting or supine position
  • Patients with severe chest wall deformity
18 Years and older
Contact: Daniel Weiler-Ravell, MD +972-54 5322422
Contact: Rachel Schatzberger, PhD +972- 4 -8500101
Echosense Ltd.
Echosense Ltd.
Not Provided
Principal Investigator: Moshe Person, MD Elisha Hospital
Echosense Ltd.
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP